{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:20:55Z","timestamp":1777911655961,"version":"3.51.4"},"reference-count":23,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>The prognostic value of CSF biomarkers in patients with idiopathic normal pressure hydrocephalus (iNPH) has not been adequately studied to date. The aim of this study was to identify CSF markers of favorable surgical outcome in patients with iNPH undergoing the insertion of a ventriculoperitoneal shunt.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Ventricular CSF was collected intraoperatively from 22 patients with iNPH and enzyme-linked immunosorbent assay was used to analyze the levels of amyloid-\u03b2 1\u201342 (A\u03b2<jats:sub>1\u201342<\/jats:sub>) and total tau protein. The Black grading scale was used to assess outcomes at 6 months. Receiver operating characteristic (ROC) curves were obtained and discriminant function analysis was undertaken to provide sensitivity and specificity figures for each marker as well as their combination.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The mean age of the patients was 71.45 years (\u00b1 9.5 years [SD]). Follow-up was achieved in 21 patients. Seventeen patients had a favorable outcome and 4 patients had unfavorable outcome at 6 months. An A\u03b2<jats:sub>1\u201342<\/jats:sub> level of 180 pg\/ml had a sensitivity of 35% and a specificity of 20% for predicting a favorable outcome at 6 months. A total tau level of 767 pg\/ml will have a sensitivity of 17% and a specificity of 20% for predicting a favorable outcome at 6 months. A combination of A\u03b2<jats:sub>1\u201342<\/jats:sub> and total tau levels predicted favorable outcomes with a sensitivity of 80% and specificity of 82.4%.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this pilot study a combination of A\u03b2<jats:sub>1\u201342<\/jats:sub> levels and total tau protein levels predicted favorable surgical outcomes at 6 months with adequate accuracy to be of clinical use. Further study in a larger group with longer follow-up is warranted.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2011.2.jns101316","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T14:09:59Z","timestamp":1301062199000},"page":"145-150","source":"Crossref","is-referenced-by-count":38,"title":["Use of cerebrospinal fluid amyloid-\u03b2 and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus"],"prefix":"10.3171","volume":"115","author":[{"given":"Andrew","family":"Tarnaris","sequence":"first","affiliation":[{"name":"Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed. K.","family":"Toma","sequence":"additional","affiliation":[{"name":"Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles D.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Neuroimmunology, Institute of Neurology, Queen Square, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Keir","sequence":"additional","affiliation":[{"name":"Department of Neuroimmunology, Institute of Neurology, Queen Square, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil D.","family":"Kitchen","sequence":"additional","affiliation":[{"name":"Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence D.","family":"Watkins","sequence":"additional","affiliation":[{"name":"Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-jns101316","series-title":"Neurosurgery","first-page":"655","article-title":"Communicating hydrocephalus in adults: prediction of outcome after ventricular shunting procedures","volume":"26","author":"Benzel","year":"1990"},{"key":"b2-jns101316","series-title":"J Neurosurg","first-page":"371","article-title":"Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients","volume":"52","author":"Black","year":"1980"},{"key":"b3-jns101316","series-title":"Clin Neurosurg","first-page":"632","article-title":"CSF shunts for dementia, incontinence, and gait disturbance","volume":"32","author":"Black","year":"1985"},{"key":"b4-jns101316","series-title":"J Neurol Sci","first-page":"54","article-title":"Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: a prospective study in a Japanese population","volume":"277","author":"Iseki","year":"2008"},{"key":"b5-jns101316","series-title":"Cerebrospinal Fluid Res","first-page":"19","article-title":"Hydrocephalus 2008, 17\u201320th September, Hannover Germany: a conference report","volume":"5","author":"Jones","year":"2008"},{"key":"b6-jns101316","series-title":"Neurosurgery","first-page":"S40","article-title":"Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients","volume":"57","author":"Klinge","year":"2005"},{"key":"b7-jns101316","series-title":"J Neurochem","first-page":"1515","article-title":"Brain metabolism in adult chronic hydrocephalus","volume":"106","author":"Kondziella","year":"2008"},{"key":"b8-jns101316","series-title":"Acta Neurochir Suppl","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-211-98811-4_19","article-title":"Is it possible to minimize overdrainage complications with gravitational units in patients with idiopathic normal pressure hydrocephalus? Protocol of the randomized controlled SVASONA Trial (ISRCTN51046698)","volume":"106","author":"Lemcke","year":"2010"},{"issue":"3 Suppl","key":"b9-jns101316","series-title":"Neurosurgery","first-page":"S17","article-title":"The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus","volume":"57","author":"Marmarou","year":"2005"},{"key":"b12-jns101316","series-title":"Nat Rev Mol Cell Biol","first-page":"891","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005"},{"key":"b10-jns101316","series-title":"Neurosurgery","first-page":"397","article-title":"Cognitive recovery in idiopathic normal pressure hydrocephalus: a prospective study","volume":"35","author":"Raftopoulos","year":"1994"},{"issue":"3 Suppl","key":"b11-jns101316","series-title":"Neurosurgery","first-page":"S4","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005"},{"key":"b13-jns101316","series-title":"Neurol Sci","first-page":"283","article-title":"CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment","volume":"31","author":"Scollato","year":"2010"},{"key":"b14-jns101316","series-title":"Brain","first-page":"947","article-title":"Normal pressure hydrocephalus (NPH): ischaemia, CSF stagnation or both","volume":"127","author":"Silverberg","year":"2004"},{"key":"b15-jns101316","series-title":"Lancet Neurol","first-page":"506","article-title":"Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis","volume":"2","author":"Silverberg","year":"2003"},{"key":"b16-jns101316","series-title":"Neuro Endocrinol Lett","first-page":"647","article-title":"Abnormalities of tauprotein and beta-amyloid in brain ventricle cerebrospinal fluid","volume":"30","author":"Talab","year":"2009"},{"key":"b17-jns101316","series-title":"Biochem Biophys Res Commun","first-page":"834","article-title":"Biochemical evidence for the long-tail form (A beta 1-42\/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease","volume":"205","author":"Tamaoka","year":"1994"},{"key":"b18-jns101316","series-title":"Neurobiol Aging","first-page":"707","article-title":"Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha","volume":"24","author":"Tarkowski","year":"2003"},{"key":"b19-jns101316","series-title":"J Neurol Neurosurg Psychiatry","first-page":"1130","article-title":"The longitudinal profile of CSF markers during external lumbar drainage","volume":"80","author":"Tarnaris","year":"2009"},{"key":"b20-jns101316","series-title":"Biomarkers Med","first-page":"787","article-title":"Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus","volume":"3","author":"Tarnaris","year":"2009"},{"key":"b21-jns101316","series-title":"Cerebrospinal Fluid Res","first-page":"11","article-title":"Biomarkers in chronic adult hydrocephalus","volume":"3","author":"Tarnaris","year":"2006"},{"key":"b22-jns101316","series-title":"Cerebrospinal Fluid Res","first-page":"9","article-title":"Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus","volume":"5","author":"Tullberg","year":"2008"},{"key":"b23-jns101316","series-title":"Neurology","first-page":"1122","article-title":"CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus","volume":"50","author":"Tullberg","year":"1998"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/115\/1\/article-p145.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/115\/1\/article-p145.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/115\/1\/article-p145.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T03:12:41Z","timestamp":1679886761000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/115\/1\/article-p145.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":23,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2011.2.jns101316","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}